Page 213 - 2021_06-Haematologica-web

Host genomics of HIV-related lymphoma
38. Lappalainen T, Sammeth M, Friedländer MR, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013;501(7468):506-511.
39. Piasecka B, Duffy D, Urrutia A, et al. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. PNAS. 2018;115(3):e488-E497.
40. Mohammadi P, Desfarges S, Bartha I, et al. 24 hours in the life of HIV-1 in a T cell line. PLOS Pathogens. 2013;9(1):e1003161.
41. Alpern D, Gardeux V, Russeil J, et al. BRB- seq: ultra-affordable high-throughput tran- scriptomics enabled by bulk RNA barcoding and sequencing. Genome Biol. 2019;20(1): 71.
42. Janssens R, Struyf S, Proost P. The unique structural and functional features of CXCL12. Cell Mol Immunol. 2018;15(4): 299-311.
43.Lim U, Kocarnik JM, Bush WS, et al. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: The
PAGE Consortium. PLoS One. 2014;9(3):
e89791.
44. Sei S, O’Neill DP, Stewart SK, et al. Increased
level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Cancer Res. 2001;61(13):5028-5037.
45. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin’s lymphoma in human immunodeficiency virus-1–infected individ- uals. Blood. 1999;93(6):1838-1842.
46.Meng W, Xue S, Chen Y. The role of CXCL12 in tumor microenvironment. Gene. 2018;641:105-110.
47.Peled A, Klein S, Beider K, Burger JA, Abraham M. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malig- nancies. Cytokine. 2018;109:11-16.
48.Piovan E, Tosello V, Indraccolo S, et al. Chemokine receptor expression in EBV- associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis
in lymphoma generation. Blood. 2005;105
(3):931-939.
49.Vijay J, Gauthier M-F, Biswell RL, et al.
Single-cell analysis of human adipose tissue identifies depot- and disease-specific cell types. Nat Metab. 2020;2(1):97-109.
50. Strober BJ, Elorbany R, Rhodes K, et al. Dynamic genetic regulation of gene expres- sion during cellular differentiation. Science. 2019;364(6447):1287-1290.
51.Quigley M, Pereyra F, Nilsson B, et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med. 2010;16(10):1147-1151.
52.Gasser O, Bihl FK, Wolbers M, Loggi E, Steffen I, Hirsch HH. HIV patients develop- ing primary CNS lymphoma lack EBV-spe- cific CD4þ T cell function irrespective of absolute CD4þ T cell counts. PLoS Med. 2007;4(3):6.
53. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues.
haematologica | 2021; 106(8)
2241